Press "Enter" to skip to content

Emcure launches generic metastatic breast cancer drug in India

The company will manufacture the product at its plant at Hinjewadi in Pune and market it at a cost which will be approximately 40 per cent less than the innovator brand, Emcure Pharmaceuticals said.

Original source:

Also Read:   USFDA issues 5 observations to Dr Reddy's plant in Hyderabad